Breaking News Instant updates and real-time market news.

ARES

Ares Management

$36.88 /

-0.41 (-1.10%)

06:43
01/22/20
01/22
06:43
01/22/20
06:43

Ares Management appoints Naseem Sagati Aghili as General Counsel

Ares Management announced that Naseem Sagati Aghili has been appointed to the role of General Counsel and Secretary of Ares, effective January 1. Ms. Sagati Aghili had served as Co-General Counsel of Ares since 2019 alongside Michael Weiner, who has been appointed as Head of Public Policy & Legislative Affairs. Weiner will remain available through Ms. Sagati Aghili's transition to General Counsel. Sagati Aghili joined Ares in 2009 and is a Partner and member of its Management Committee. During her more than 10 years at the Firm, Naseem has served in various roles in Ares' Legal Group. Prior to joining Ares, Ms. Sagati Aghili was with Proskauer Rose LLP, where she focused on mergers and acquisitions, securities offerings and general corporate matters. Weiner has been with Ares since 2006, having served as General Counsel until 2019 and Co-General Counsel over the last year. He will continue as a Partner and member of the Firm's Management Committee.

  • 13

    Feb

  • 26

    Feb

ARES Ares Management
$36.88 /

-0.41 (-1.10%)

12/19/19 Wells Fargo
Wells stays bullish on alternative asset managers into 2020, Ares top pick
12/12/19 UBS
Carlyle Group downgraded to Neutral from Buy at UBS
10/14/19 BofA
BofA gets more selective in alternative asset managers, downgrades Blackstone
10/07/19 BMO Capital
KKR, Victory Capital, Apollo Global top BMO Capital picks among asset managers

TODAY'S FREE FLY STORIES

Upgrade
Flagstar Bancorp upgraded to Overweight from Neutral at Piper Sandler » 06:07
02/26/20
02/26
06:07
02/26/20
06:07
FBC

Flagstar Bancorp

$34.01 /

-0.46 (-1.33%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Smart Sand reports Q4 EPS 5cc, consensus 17c » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
SND

Smart Sand

$1.79 /

-0.085 (-4.55%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
BBVA reinstated with a Neutral at Redburn » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
BBVA

BBVA

$5.07 /

-0.2 (-3.80%)

Redburn reinstated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Banco Santander resinstated with a Buy at Redburn » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
SAN

Banco Santander

$3.72 /

-0.145 (-3.75%)

Redburn reinstated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lowe's sees FY20 adj. EPS $6.45-$6.58, consensus $6.67 » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
LOW

Lowe's

$118.69 /

-4.215 (-3.43%)

Sees FY20 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
United Therapeutics reports Q4 EPS $1.96, consensus $2.65 » 06:05
02/26/20
02/26
06:05
02/26/20
06:05
UTHR

United Therapeutics

$112.96 /

-2.33 (-2.02%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
LivaNova sees FY20 adjusted EPS $3.10-$3.30, consensus $3.30 » 06:04
02/26/20
02/26
06:04
02/26/20
06:04
LIVN

LivaNova

$66.65 /

-2.25 (-3.27%)

Expects FY20 revenues to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Tenet upgraded to Neutral after 26% two-month selloff at JPMorgan » 06:04
02/26/20
02/26
06:04
02/26/20
06:04
THC

Tenet

$29.20 /

-3.49 (-10.68%)

JPMorgan analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
National Vision reports Q4 adj. comparable store sales growth of 8.1%  06:04
02/26/20
02/26
06:04
02/26/20
06:04
EYE

National Vision

$33.82 /

-0.71 (-2.06%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lowe's reports Q4 adj. EPS 94c, consensus 91c » 06:04
02/26/20
02/26
06:04
02/26/20
06:04
LOW

Lowe's

$118.69 /

-4.215 (-3.43%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
National Vision sees FY20 adjusted EPS 80c-85c, consensus 79c » 06:03
02/26/20
02/26
06:03
02/26/20
06:03
EYE

National Vision

$33.82 /

-0.71 (-2.06%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
LivaNova reports Q4 adjusted EPS $1.00, consensus 98c » 06:02
02/26/20
02/26
06:02
02/26/20
06:02
LIVN

LivaNova

$66.65 /

-2.25 (-3.27%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
CME Group upgraded to Buy from Neutral at UBS » 06:02
02/26/20
02/26
06:02
02/26/20
06:02
CME

CME Group

$208.31 /

-1.12 (-0.53%)

UBS analyst Alex Kramm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
National Vision reports Q4 adjusted EPS 11c, consensus 1c » 06:01
02/26/20
02/26
06:01
02/26/20
06:01
EYE

National Vision

$33.82 /

-0.71 (-2.06%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Citi upgrades Intercept to Buy on peak sales potential of Ocaliva » 06:00
02/26/20
02/26
06:00
02/26/20
06:00
ICPT

Intercept

$84.52 /

-6.25 (-6.89%)

, CBAY

CymaBay

$1.65 /

-0.045 (-2.65%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Broadridge initiated with a Buy at BTIG » 05:59
02/26/20
02/26
05:59
02/26/20
05:59
BR

Broadridge

$112.48 /

-4.005 (-3.44%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Facebook to ban ads that promise to cure coronavirus, Business Insider reports » 05:59
02/26/20
02/26
05:59
02/26/20
05:59
FB

Facebook

$196.75 /

-4.02 (-2.00%)

Facebook says it will now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Tesla, Panasonic end joint solar cell production partnership, Nikkei reports » 05:56
02/26/20
02/26
05:56
02/26/20
05:56
TSLA

Tesla

$799.75 /

-34.07 (-4.09%)

, PCRFY

Panasonic

$0.00 /

+ (+0.00%)

Tesla (TSLA) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
VerticalNet initiated with an Outperform at Cowen » 05:56
02/26/20
02/26
05:56
02/26/20
05:56
VERT

VerticalNet

$0.00 /

+ (+0.00%)

Cowen analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Amarin shares can rally 20% on litigation win in March, say Citi » 05:56
02/26/20
02/26
05:56
02/26/20
05:56
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

Citi analyst Joel Beatty…

Citi analyst Joel Beatty maintains a Buy rating on Amarin with a $24 price target following last night's Q4 results. The stock in premarket trading is down 32c to $17.18. The analyst believes Amarin will be successful in its Vascepa patent litigation and sees 20% upside upon the court's decision in March. However, the stock can drop 50% on a negative ruling, Beatty tells investors in a post-earnings research note. In addition, the analyst believes Vascepa sales growth will be strong throughout 2020. The biggest factor impacting Amarin's stock price over the next year is monetizing the European rights to Vascepa, and the implied valuation of the total company from any type of partnership or other transaction that takes place, contends the analyst. He thinks an outright acquisition of Amarin would likely be the best near-term outcome for stockholders. However, if the end of 2020 is reached without some sort of European partnership appearing imminent, it is unlikely the stock price will be much higher at year-end compared to today, contends Beatty.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Resonant to host business news update webinar » 05:55
02/26/20
02/26
05:55
02/26/20
05:55
RESN

Resonant

$1.68 /

-0.08 (-4.55%)

Webinar to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Conference/Events
ConocoPhillips management to meet with JPMorgan » 05:55
02/26/20
02/26
05:55
02/26/20
05:55
COP

ConocoPhillips

$53.83 /

-2.55 (-4.52%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Interface sees FY20 adj. EPS $1.60-$1.70, consensus $1.69 » 05:49
02/26/20
02/26
05:49
02/26/20
05:49
TILE

Interface

$15.70 /

-0.4 (-2.48%)

Sees FY20 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Alcon upgraded to Buy from Hold at Berenberg » 05:49
02/26/20
02/26
05:49
02/26/20
05:49
ALC

Alcon

$58.75 /

-1.755 (-2.90%)

Berenberg analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Interface reports Q4 adj. EPS 46c, consensus 41c » 05:48
02/26/20
02/26
05:48
02/26/20
05:48
TILE

Interface

$15.70 /

-0.4 (-2.48%)

Reports Q4 revenue $339M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.